Log in to save to my catalogue

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literatur...

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literatur...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1812885230

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature

About this item

Full title

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature

Publisher

Oxford, UK: Oxford University Press

Journal title

Inflammatory bowel diseases, 2016-09, Vol.22 (9), p.2255-2264

Language

English

Formats

Publication information

Publisher

Oxford, UK: Oxford University Press

More information

Scope and Contents

Contents

Inflammatory bowel disease (IBD) is an inflammatory disorder of the intestine that affects an estimated 329 per 100,000 people in the United States and is increasing in incidence within a number of cultures worldwide. Likely due to its incompletely understood pathophysiology and etiology, the standard treatments for IBD are only efficacious in subs...

Alternative Titles

Full title

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1812885230

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1812885230

Other Identifiers

ISSN

1078-0998

E-ISSN

1536-4844

DOI

10.1097/MIB.0000000000000818

How to access this item